S100A4, S100B, S100A14, S100P expressions are associated with poor prognosis [8–12], moreover,high cytoplasmic S100A10 staining is significantly associated with reduced overall survival (OS) and progression-free survival (PFS) in serous ovarian cancer [13, 14]. This evidence concerns the gene S100A10 and ovarian serous adenocarcinoma.